This Article contains typographical errors in in the Methods section under subheading ‘Cell lines and culture conditions’
“insulin (1 mg/mL), epidermal growth factor (12.5 ng/mL), hydrocortisone (2.8 mM), 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 1 mM sodium pyruvate, 0.1 mM non-essential amino acids and 50 mg/mL gentamycin reagent (now called αHE; all supplements from Wisent Bioproducts, Montreal, QC) as previously described”
should read
“insulin (1 µg/mL), epidermal growth factor (12.5 ng/mL), hydrocortisone (2.8 µM), 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 1 mM sodium pyruvate, 0.1 mM non-essential amino acids and 50 µg/mL gentamycin reagent (now called αHE; all supplements from Wisent Bioproducts, Montreal, QC) as previously described”
Additional information
The online version of the original article can be found at 10.1038/srep06315
Rights and permissions
About this article
Cite this article
MacMillan, C., Leong, H., Dales, D. et al. Correction: Corrigendum: Stage of Breast Cancer Progression Influences Cellular Response to Activation of the WNT/Planar Cell Polarity Pathway. Sci Rep 5, 7942 (2015). https://doi.org/10.1038/srep07942
Published:
DOI: https://doi.org/10.1038/srep07942
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
